Challenge: expanding access to hepatitis B care and treatment.





Effective, low-cost antiviral medications can treat hepatitis B, cutting liver cancer risk in half. However, of the estimated 254 million people with hepatitis B, only 13% are diagnosed and a scant number receive treatment.

The World Health Organization (WHO) recently simplified treatment criteria, increasing eligibility for treatment by non-liver specialists. To improve the health of people with hepatitis B in low- and middle-income countries, the recently launched Center for Operational Research on Hepatitis B is seeking to develop pathways of simplified care and integrated service delivery.





Comments

Popular posts from this blog

Achievement: model national programmes to test, treat and cure hepatitis C.

Support the global effort to eliminate viral hepatitis.

Advancing Global Solidarity to Eliminate Hepatitis.